Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Benefit of Elevation of HDL-C on Cardiovascular Outcomes in Women

This study has been completed.
General Clinical Research Center (GCRC)
Kos Pharmaceuticals
Information provided by:
Cedars-Sinai Medical Center Identifier:
First received: December 26, 2007
Last updated: September 13, 2011
Last verified: December 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2005
  Primary Completion Date: November 2005 (Final data collection date for primary outcome measure)